Researchers have demonstrably boosted this progress of a novel therapy for cardiac amyloidosis, leveraging Attruby. Early clinical results suggests significant benefits for individuals diagnosed by this severe disease. The emphasis highlights BridgeBio's focus to treating critical patient needs in a heart disease arena. Attruby: BridgeB… Read More